VC
Value Add VC
โšกHomePulseโšกHelpful Apps๐Ÿ“Blog
โ† Value Add PulseIPO$26.5B IPO

SK Hynix Raises $26.5B in Largest-Ever Foreign US IPO

SK Hynix priced 177.9 million ADRs at $149 each to raise $26.5 billion on Nasdaq, topping Alibaba's 2014 debut as the largest US listing ever by a foreign company, and popped 14% at the open.

$26.5 billion
Amount raised
$149 each
ADR price
177.9 million ADRs
Shares sold
+14%
Opening pop
7x+
Oversubscription
TC
Trace Cohen
Early-stage VC & angel ยท Founder, New York Venture Partners
July 10, 2026
2 min read
ShareXLinkedInEmail
THE RUNDOWN
1

SK Hynix, the South Korean memory-chip giant, sold 177.9 million American depositary shares at $149 each on July 10, raising $26.5 billion and topping Alibaba's $25 billion 2014 IPO as the largest-ever US debut by a non-American company

2

The offering was more than seven times oversubscribed, and the stock, trading under the temporary ticker SKHYV, opened 14% above its IPO price and kept climbing through early trading -- a striking reception given how few foreign chipmakers have attempted a full US primary listing at this scale

3

SK Hynix said in its regulatory filing that proceeds will fund new production facilities in Korea to expand high-bandwidth memory (HBM) manufacturing, the specialized chip category that has become a critical bottleneck for Nvidia's AI accelerators and the broader AI data-center buildout

4

The listing lands the same week Wall Street is publicly debating whether AI infrastructure spending is outrunning actual utilization, with a separate VentureBeat survey finding 86% of enterprises running their own GPUs report utilization at half capacity or less

TC
The VC Read ยท Trace's TakeTrace Cohen

A seven-times-oversubscribed, 14%-pop debut for a Korean memory chipmaker tells you public markets aren't actually skeptical about AI infrastructure -- they're skeptical about which layer of it captures the value. HBM is the one bottleneck in the entire AI hardware stack that isn't getting solved by more capital alone, which is exactly why investors piled into the one name that's structurally scarce rather than just structurally expensive.

SK Hynix priced its US share offering at $149 per American depositary share on July 9 and began trading on Nasdaq under the temporary ticker SKHYV on July 10, raising $26.5 billion in what is now the largest-ever US listing by a foreign company -- surpassing Alibaba's $25 billion IPO from 2014, a record that had stood for more than a decade. The South Korean memory-chip maker sold 177.9 million ADRs, structured so US investors could buy in at roughly a tenth of what a full share costs on the Korea Exchange in Seoul.

Demand was extraordinary by any measure: the offering was more than seven times oversubscribed, and the stock opened 14% above its IPO price before continuing to climb through early trading. That kind of reception for a foreign primary listing of this size is rare, and it reflects how central SK Hynix has become to the physical infrastructure of the AI boom rather than investor enthusiasm for Korean equities broadly.

SK Hynix's regulatory filing specifies that proceeds will fund new production facilities in Korea dedicated to expanding manufacturing of high-bandwidth memory, or HBM -- the specialized, stacked memory chips that sit alongside Nvidia's GPUs in AI accelerators and have become one of the tightest supply bottlenecks in the entire AI hardware stack. SK Hynix already supplies HBM to Nvidia at scale, competing primarily against Samsung and Micron in a three-way race that's arguably more consequential to near-term AI compute availability than the GPU race itself, since HBM shortages can bottleneck accelerator output even when GPU die supply is sufficient.

โ€œThe timing of the listing is notable against a backdrop of growing skepticism about AI infrastructure utilization.โ€

The timing of the listing is notable against a backdrop of growing skepticism about AI infrastructure utilization. The same week SK Hynix debuted, VentureBeat published survey data showing 86% of enterprises that run their own GPUs report utilization of 50% or less -- a genuine disconnect between how aggressively hyperscalers and memory suppliers are building capacity and how much of the deployed compute is actually earning a return. SK Hynix's own memory business benefits regardless of that utilization gap, since HBM demand is driven by hyperscaler capex commitments made well in advance of actual workload deployment.

For founders and investors, SK Hynix's oversubscribed debut is a signal that public-market appetite for AI-infrastructure exposure remains genuinely strong even as skepticism about buildout pace grows in parallel -- the two aren't mutually exclusive, and sophisticated capital is willing to buy the picks-and-shovels layer even while debating whether the mine itself is being overbuilt. For LPs benchmarking IPO market health, this listing alongside SpaceX's earlier $75 billion debut confirms that 2026's mega-IPO wave is real, even if it remains concentrated in a handful of infrastructure-critical names rather than broad-based issuance.

The bear case: SK Hynix's valuation now embeds continued explosive HBM demand growth, and any slowdown in hyperscaler AI capex -- or evidence that the 86% underutilization VentureBeat documented starts constraining future GPU and memory orders -- would hit the stock directly. What to watch next: how SKHYV trades once its temporary ticker converts and lockups begin expiring, and whether Samsung or Micron respond with their own US listing ambitions now that SK Hynix has proven the market's appetite.

ShareXLinkedInEmail
More onSK Hynix โ†’

Originally reported by TechCrunch. Analysis and editorial commentary by Value Add Pulse.

โ† Back to Pulse

THE WIRE in your inbox

Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

IPO

AI Infrastructure Firm Corvex Goes Public via Movano Reverse Merger

AI infrastructure company Corvex is going public through a reverse merger with public shell Movano Inc., with Corvex shareholders projected to own about 94.8% of the combined entity.

IPO$180M+ partnership payments

Doudna-Founded Scribe Therapeutics Files S-1/A for Nasdaq IPO

Scribe Therapeutics, the CRISPR biotech co-founded by Nobel laureate Jennifer Doudna, amended its S-1 to list on Nasdaq under ticker SCTX, backed by more than $180 million in Sanofi and Eli Lilly partnership payments.

IPO

Laser Photonics Files Fresh S-1 for Warrant Share Resale

Laser Photonics Corp, a Nasdaq-listed industrial laser-cleaning maker, filed its third S-1 of 2026 on July 10, continuing a pattern of registering shares tied to inducement and placement-agent warrants.

@Trace_Cohenยทt@nyvp.com